OMB APPROVAL
--------------------------
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response... 11
--------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO._______)*
Alnylam Pharmaceuticals, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.01 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
02043Q107
------------------------------
(CUSIP Number)
December 31, 2004
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 20 pages
CUSIP NO. 02043Q107 13G PAGE 2 OF 20 PAGES
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Atlas Venture Fund V, L.P.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,006,195 shares
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0 shares
8 SHARED DISPOSITIVE POWER
2,006,195 shares
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,006,195 shares
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
Page 2 of 20 pages
CUSIP NO. 02043Q107 13G PAGE 3 OF 20 PAGES
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Atlas Venture Parallel Fund V-A, C.V.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Netherlands
5 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,006,195 shares
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0 shares
8 SHARED DISPOSITIVE POWER
2,006,195 shares
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,006,195 shares
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
Page 3 of 20 pages
CUSIP NO. 02043Q107 13G PAGE 4 OF 20 PAGES
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Atlas Venture Parallel Fund V-B, C.V.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Netherlands
5 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,006,195 shares
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0 shares
8 SHARED DISPOSITIVE POWER
2,006,195 shares
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,006,195 shares
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
Page 4 of 20 pages
CUSIP NO. 02043Q107 13G PAGE 5 OF 20 PAGES
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Atlas Venture Entrepreneurs' Fund V, L.P.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,006,195 shares
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0 shares
8 SHARED DISPOSITIVE POWER
2,006,195 shares
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,006,195 shares
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
Page 5 of 20 pages
CUSIP NO. 02043Q107 13G PAGE 6 OF 20 PAGES
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Atlas Venture Fund VI, L.P.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,006,195 shares
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0 shares
8 SHARED DISPOSITIVE POWER
2,006,195 shares
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,006,195 shares
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
Page 6 of 20 pages
CUSIP NO. 02043Q107 13G PAGE 7 OF 20 PAGES
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Atlas Venture Entrepreneurs' Fund VI, L.P.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,006,195 shares
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0 shares
8 SHARED DISPOSITIVE POWER
2,006,195 shares
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,006,195 shares
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
Page 7 of 20 pages
CUSIP NO. 02043Q107 13G PAGE 8 OF 20 PAGES
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Atlas Venture Fund VI GmbH & Co. KG.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Germany
5 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,006,195 shares
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0 shares
8 SHARED DISPOSITIVE POWER
2,006,195 shares
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,006,195 shares
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
Page 8 of 20 pages
CUSIP NO. 02043Q107 13G PAGE 9 OF 20 PAGES
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Atlas Venture Associates V, L.P.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,006,195 shares
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0 shares
8 SHARED DISPOSITIVE POWER
2,006,195 shares
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,006,195 shares
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
Page 9 of 20 pages
CUSIP NO. 02043Q107 13G PAGE 10 OF 20 PAGES
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Atlas Venture Associates VI, L.P.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,006,195 shares
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0 shares
8 SHARED DISPOSITIVE POWER
2,006,195 shares
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,006,195 shares
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
Page 10 of 20 pages
CUSIP NO. 02043Q107 13G PAGE 11 OF 20 PAGES
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Atlas Venture Associates V, Inc.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,006,195 shares
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0 shares
8 SHARED DISPOSITIVE POWER
2,006,195 shares
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,006,195 shares
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
Page 11 of 20 pages
CUSIP NO. 02043Q107 13G PAGE 12 OF 20 PAGES
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Atlas Venture Associates VI, Inc.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,006,195 shares
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0 shares
8 SHARED DISPOSITIVE POWER
2,006,195 shares
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,006,195 shares
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
Page 12 of 20 pages
CUSIP NO. 02043Q107 13G PAGE 13 OF 20 PAGES
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Axel Bichara
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Germany
5 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,006,195 shares
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0 shares
8 SHARED DISPOSITIVE POWER
2,006,195 shares
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,006,195 shares
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
Page 13 of 20 pages
CUSIP NO. 02043Q107 13G PAGE 14 OF 20 PAGES
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Jean-Francois Formela
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
SEC USE ONLY
CITIZENSHIP OR PLACE OF ORGANIZATION
France
5 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,006,195 shares
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0 shares
8 SHARED DISPOSITIVE POWER
2,006,195 shares
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,006,195 shares
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
Page 14 of 20 pages
CUSIP NO. 02043Q107 13G PAGE 15 OF 20 PAGES
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Christopher Spray
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
SEC USE ONLY
CITIZENSHIP OR PLACE OF ORGANIZATION
United Kingdom
5 SOLE VOTING POWER
0 shares
NUMBER OF
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,006,195 shares
EACH
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 0 shares
8 SHARED DISPOSITIVE POWER
2,006,195 shares
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,006,195 shares
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
Page 15 of 20 pages
Schedule 13G
Item 1(a). Name of Issuer: Alnylam Pharmaceuticals, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
300 Third Street, Cambridge, MA 02142
Item 2(a). Name of Person Filing:
Atlas Venture Fund V, L.P. ("Atlas V"), Atlas Venture Fund
V-A, C.V. ("Atlas V-A"), Atlas Venture Fund V-B, C.V. ("Atlas
V-B"), Atlas Venture Entrepreneurs' Fund V, L.P. ("AVE V" and
together with Atlas V, Atlas V-A and Atlas V-B, the "Atlas V
Funds"), Atlas Venture Fund VI, L.P. ("Atlas VI"), Atlas
Venture Fund VI GmbH & Co. KG ("Atlas VI GmbH"), Atlas Venture
Entrepreneurs' Fund VI, L.P. ("AVE VI"), Atlas Venture
Associates V, L.P. ("AVA V LP"), Atlas Venture Associates VI,
L.P. ("AVA VI LP"), Atlas Venture Associates V, Inc. ("AVA V
Inc."), Atlas Venture Associates VI, Inc. ("AVA VI Inc."),
Axel Bichara ("Bichara"), Jean-Francois Formela ("Formela")
and Christopher Spray ("Spray"). Atlas V, Atlas V-A, Atlas
V-B, AVE V, Atlas VI, Atlas VI GmbH and AVE VI are referred to
individually herein as a "Fund" and collectively as the
"Funds". The persons and entities named in this Item 2(a) are
referred to individually herein as a "Filing Person" and
collectively as the "Filing Persons".
AVA V Inc. is the sole general partner of AVA V LP. AVA V LP
is the sole general partner of the Atlas V Funds. Messrs.
Bichara, Formela and Spray are directors of AVA V Inc.
AVA VI Inc. is the sole general partner of AVA VI LP. AVA VI
LP is the sole general partner of Atlas VI and AVE VI and the
managing limited partner of Atlas VI GmbH. Messrs. Bichara,
Formela and Spray are directors of AVA VI Inc.
Item 2(b). Address of Principal Business Office or, if None, Residence:
The principal business office of each of the Filing Persons
is:
890 Winter Street, Suite 320
Waltham, MA 02451
Item 2(c). Citizenship: Atlas V, AVE V, Atlas VI, AVE VI, AVA V LP and
AVA VI LP is each a limited partnership formed under the laws
of the state of Delaware. AVA V Inc. and AVA VI Inc. is each a
corporation formed under the laws of the state of Delaware.
Atlas V-A and Atlas V-B is each a limited partnership formed
under the laws of The Netherlands. Atlas VI GmbH is a limited
partnership formed under the laws of Germany. Mr. Bichara is a
citizen of Germany. Mr. Formela is a citizen of France. Mr.
Spray is a citizen of the United Kingdom.
Item 2(d). Title of Class of Securities: Common Stock, $0.01 par value
per share (the "Common Stock").
Item 2(e). CUSIP Number: 02043Q107
Page 16 of 20 pages
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or
13d-2(b) or (c), Check Whether the Person Filing is a:
Not Applicable.
Item 4. Ownership.
(a) Amount Beneficially Owned: Atlas V is the record holder of
634,331 shares of Common Stock as of December 31, 2004 (the
"Atlas V Shares"). Atlas V-A is the record holder of 78,794
shares of Common Stock as of December 31, 2004 (the "Atlas V-A
Shares"). Atlas V-B is the record holder of 78,794 shares of
Common Stock as of December 31, 2004 (the "Atlas V-B Shares").
AVE V is the record holder of 10,557 shares of Common Stock as
of December 31, 2004 (the "AVE V Shares"). Atlas VI is the
record holder of 1,151,536 shares of Common Stock as of
December 31, 2004 (the "Atlas VI Shares"). Atlas VI GmbH is
the record holder of 21,085 shares of Common Stock as of
December 31, 2004 (the "Atlas VI GmbH Shares"). AVE VI is the
record holder of 31,098 shares of Common Stock as of December
31, 2004 (the "AVE VI Shares"). By virtue of their
relationship as affiliated limited partnerships, each Fund may
be deemed to share the power to direct the disposition and
vote the Atlas V Shares, the Atlas V-A Shares, the Atlas V-B
Shares, the AVE V Shares, the Atlas VI Shares, the Atlas VI
GmbH Shares and the AVE VI Shares, for an aggregate of
2,006,195 shares of Common Stock (the "Record Shares"). As
general partner or managing limited partner, as the case may
be, of certain of the Funds, and by virtue of the Funds
relationship as affiliated limited partnerships, each of AVA V
LP and AVA VI LP may also be deemed to beneficially own the
Record Shares. As the general partner of AVA V LP and AVA VI
LP respectively, AVA V Inc. and AVA VI Inc. may also be deemed
to beneficially own the Record Shares. In their capacities as
directors of AVA V Inc. and AVA VI Inc. each of Messrs.
Bichara, Formela and Spray may be deemed to beneficially own
the Record Shares.
Each Filing Person disclaims beneficial ownership of the
Record Shares except for such shares, if any, such Filing
Person holds of record.
(b) Percent of Class:
Each Filing Person: 9.99%
(c) Number of shares as to which the person has:
(i) sole power to vote or to direct the vote:
0
(ii) shared power to vote or to direct the vote:
2,006,195 for each Filing Person
(iii) sole power to dispose or direct the disposition of:
0
Page 17 of 20 pages
(iv) shared power to dispose or direct the disposition of:
2,006,195 for each Filing Person
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
Not Applicable.
Item 7. Identification and Classification of the Subsidiary which
Acquired the Security Being Reported on By the Parent Holding
Company.
Not Applicable.
Item 8. Identification and Classification of Members of the Group.
Not Applicable. The Filing Persons expressly disclaim
membership in a "group" as used in Rule 13d-5(b)(1).
Item 9. Notice of Dissolution of Group.
Not Applicable.
Item 10. Certification.
Not Applicable. This statement on Schedule 13G is not filed
pursuant to Rule 13d-1(b) or Rule 13d-1(c).
Page 18 of 20 pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 9, 2005
*
-----------------------------------------
Axel Bichara
*
-----------------------------------------
Jean-Francois Formela
*
-----------------------------------------
Christopher Spray
Atlas Venture Fund VI, L.P.
Atlas Venture Entrepreneurs' Fund VI, L.P.
By: Atlas Venture Associates VI, L.P.
their general partner
By: Atlas Venture Associates VI, Inc.
its general partner
By: *
--------------------------------------
Name: Jeanne Larkin Henry
----------------------------------
Title: Vice-President
----------------------------------
Atlas Venture Fund VI GmbH & Co. KG
By: Atlas Venture Associates VI, L.P.
its managing limited partner
By: Atlas Venture Associates VI, Inc.
its general partner
By: *
--------------------------------------
Name: Jeanne Larkin Henry
----------------------------------
Title: Vice-President
----------------------------------
Atlas Venture Associates VI, L.P.
By: Atlas Venture Associates VI, Inc.
its general partner
By: *
--------------------------------------
Name: Jeanne Larkin Henry
----------------------------------
Title: Vice-President
----------------------------------
Page 19 of 20 pages
Atlas Venture Associates VI, Inc.
By: *
--------------------------------------
Name: Jeanne Larkin Henry
----------------------------------
Title: Vice-President
----------------------------------
Atlas Venture Fund V, L.P.
Atlas Venture Entrepreneurs' Fund V, L.P.
Atlas Venture Parallel Fund V-A, C.V.
Atlas Venture Parallel Fund V-B, C.V.
By: Atlas Venture Associates V, L.P.
their general partner
By: Atlas Venture Associates V, Inc.
its general partner
By: *
--------------------------------------
Name: Jeanne Larkin Henry
----------------------------------
Title: Vice-President
----------------------------------
Atlas Venture Associates V, L.P.
By: Atlas Venture Associates V, Inc.
its general partner
By: *
--------------------------------------
Name: Jeanne Larkin Henry
----------------------------------
Title: Vice-President
----------------------------------
Atlas Venture Associates V, Inc.
By: *
--------------------------------------
Name: Jeanne Larkin Henry
----------------------------------
Title: Vice-President
----------------------------------
* By: /s/ Jeanne Larkin Henry
----------------------------
By Jeanne Larkin Henry in her
individual capacity and as
Attorney-in-Fact
Page 20 of 20 pages
Exhibit 1
AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities and Exchange Act of
1934, each of the undersigned hereby agree that only one statement containing
the information required by Schedule 13G need be filed with respect to the
ownership by each of the undersigned of shares of stock of Alnylam
Pharmaceuticals, Inc. This Agreement may be executed in any number of
counterparts, each of which shall be deemed an original.
Dated: February 9, 2005
*
-----------------------------------------
Axel Bichara
*
-----------------------------------------
Jean-Francois Formela
*
-----------------------------------------
Christopher Spray
Atlas Venture Fund VI, L.P.
Atlas Venture Entrepreneurs' Fund VI, L.P.
By: Atlas Venture Associates VI, L.P.
their general partner
By: Atlas Venture Associates VI, Inc.
its general partner
By: *
--------------------------------------
Name: Jeanne Larkin Henry
----------------------------------
Title: Vice-President
----------------------------------
Atlas Venture Fund VI GmbH & Co. KG
By: Atlas Venture Associates VI, L.P.
its managing limited partner
By: Atlas Venture Associates VI, Inc.
its general partner
By: *
--------------------------------------
Name: Jeanne Larkin Henry
----------------------------------
Title: Vice-President
----------------------------------
Atlas Venture Associates VI, L.P.
By: Atlas Venture Associates VI, Inc.
its general partner
By: *
--------------------------------------
Name: Jeanne Larkin Henry
----------------------------------
Title: Vice-President
----------------------------------
Atlas Venture Associates VI, Inc.
By: *
--------------------------------------
Name: Jeanne Larkin Henry
----------------------------------
Title: Vice-President
----------------------------------
Atlas Venture Fund V, L.P.
Atlas Venture Entrepreneurs' Fund V, L.P.
Atlas Venture Parallel Fund V-A, C.V.
Atlas Venture Parallel Fund V-B, C.V.
By: Atlas Venture Associates V, L.P.
their general partner
By: Atlas Venture Associates V, Inc.
its general partner
By: *
--------------------------------------
Name: Jeanne Larkin Henry
----------------------------------
Title: Vice-President
----------------------------------
Atlas Venture Associates V, L.P.
By: Atlas Venture Associates V, Inc.
its general partner
By: *
--------------------------------------
Name: Jeanne Larkin Henry
----------------------------------
Title: Vice-President
----------------------------------
Atlas Venture Associates V, Inc.
By: *
--------------------------------------
Name: Jeanne Larkin Henry
----------------------------------
Title: Vice-President
----------------------------------
* By: /s/ Jeanne Larkin Henry
----------------------------
By Jeanne Larkin Henry in her
individual capacity and as
Attorney-in-Fact
Exhibit 2
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature
appears below hereby constitutes and appoints each and any of Christopher J.
Spray and Jeanne Larkin Henry his true and lawful attorney-in-fact and agent,
with full power of substitution and re-substitution, for him and in his name,
place and stead, in any and all capacities (until revoked in writing) to sign
any and all instruments, certificates and documents required to be executed on
behalf of himself individually or on behalf of each or any of Atlas Venture Fund
II, L.P., Atlas Venture Associates II, L.P., Atlas Venture Fund III, L.P., Atlas
Venture Entrepreneurs' Fund III, L.P., Atlas Venture Associates III, L.P., Atlas
Venture Associates III, Inc., Atlas Venture Fund IV, L.P., Atlas Venture
Entrepreneurs' Fund IV, L.P., Atlas Venture Parallel Fund IV-A, C.V., Atlas
Venture Parallel Fund IV-B, C.V., Atlas Venture Associates IV, L.P., Atlas
Venture Associates IV, Inc., Atlas Venture Fund V, L.P., Atlas Venture
Entrepreneurs' Fund V, L.P., Atlas Venture Parallel Fund V-A, C.V., Atlas
Venture Parallel Fund V-B, C.V., Atlas Venture Associates V, L.P., Atlas Venture
Associates V, Inc., Atlas Venture Fund VI, L.P., Atlas Venture Entrepreneurs'
Fund VI, L.P., Atlas Venture Fund VI GmbH & Co. KG, Atlas Venture Associates VI,
L.P. and Atlas Venture Associates VI, Inc. pursuant to sections 13 and 16 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), and any and
all regulations promulgated thereunder, and to file the same, with all exhibits
thereto, and any other documents in connection therewith, with the Securities
and Exchange Commission, and with any other entity when and if such is mandated
by the Exchange Act or by the By-laws of the National Association of Securities
Dealers, granting unto said attorney-in-fact and agent full power and authority
to do and perform each and every act and thing requisite and necessary fully to
all intents and purposes as he might or could do in person thereby ratifying and
confirming all that said attorney-in-fact and agent, or his substitute or
substitutes, may lawfully do or cause to be done by virtue hereof.
IN WITNESS WHEREOF, this Power of Attorney has been signed as of the
8th day of February, 2005.
/s/ Axel Bichara
-----------------------------
Axel Bichara
/s/ Jean-Francois Formela
-----------------------------
Jean-Francois Formela
/s/ Christopher Spray
-----------------------------
Christopher Spray